BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.49
+0.19 (2.60%)
At close: Nov 21, 2024, 4:00 PM
7.45
-0.04 (-0.53%)
After-hours: Nov 21, 2024, 5:59 PM EST
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$15.60
Upside
+108.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +33.51% | Nov 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +86.92% | Nov 5, 2024 |
| Barclays | Barclays | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +6.81% | Nov 5, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +113.62% | Aug 6, 2024 |
| Barclays | Barclays | Hold Maintains $6 → $7 | Hold | Maintains | $6 → $7 | -6.54% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +33.51% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +300.53% | Aug 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +60.21% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +300.53% | May 7, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | +100.27% | May 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +60.21% | Apr 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +60.21% | Jan 8, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $10 | Buy | Initiates | $10 | +33.51% | Nov 20, 2023 |
| Needham | Needham | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +60.21% | Nov 6, 2023 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +33.51% | Sep 25, 2023 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $9 → $10 | Hold → Buy | Upgrades | $9 → $10 | +33.51% | Sep 18, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.